Mental Health Parity in 2026: How to Fight Insurance Denials for Therapy and Rehab

When a health plan refuses to pay for therapy, inpatient rehabilitation, or a prescribed psychiatric medication, most Americans assume the decision is final. It rarely is. Federal law, updated most recently through the 2024 Mental Health Parity and Addiction Equity Act final rule, requires most group and individual health plans to cover mental-health and substance-use disorder benefits on the same terms as medical and surgical benefits. Despite that legal framework, denial rates for behavioral-health claims remain measurably higher than for comparable medical care. Independent audits published by state insurance departments, the U.S. Department of Labor, and academic researchers consistently document unequal medical-necessity criteria, restrictive prior-authorization protocols, and network shortfalls that would not survive scrutiny if applied to a knee replacement or a cardiology consultation. This guide explains, in plain language and using only verifiable sources, how mental-health parity actually works in 2026, why claims are denied, and what specific administrative and legal remedies patients can pursue when an insurer will not pay for treatment that a licensed clinician has determined to be medically necessary.

The Federal Parity Framework
Non-Quantitative Treatment Limitations
What the 2024 Final Rule Changed
Why Behavioral-Health Claims Are Denied
The Internal and External Appeals Process
ERISA vs. Non-ERISA Plans
State Parity Laws and Regulators
When to Retain a Mental-Health Parity Attorney
A Practical Step-by-Step Checklist
Frequently Asked Questions

The Federal Parity Framework

The core statute is the Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA), which amended the Employee Retirement Income Security Act (ERISA), the Public Health Service Act, and the Internal Revenue Code. It applies to most employer-sponsored group health plans covering more than 50 employees, individual and small-group plans sold through the Affordable Care Act marketplaces, Medicaid managed-care organizations, and the Children's Health Insurance Program.

The rule is not that insurers must cover mental-health care at all. It is that if they cover it — and every ACA-compliant plan must, because mental-health and substance-use services are essential health benefits — the financial requirements and treatment limits cannot be more restrictive than those imposed on medical and surgical benefits in the same classification.

The six benefit classifications

Parity is measured within, not across, these six categories: inpatient in-network, inpatient out-of-network, outpatient in-network, outpatient out-of-network, emergency care, and prescription drugs. A plan cannot, for example, apply a $40 copay for medical outpatient visits and a $75 copay for psychotherapy in the same classification.

Two women in professional attire talking across a desk during a therapy or counseling session

Non-Quantitative Treatment Limitations

Most modern denials are not about copays or visit caps, which are easy to audit. They involve non-quantitative treatment limitations (NQTLs) — the operational rules that determine when care is authorized, how providers are credentialed, and what qualifies as medically necessary. Common NQTLs include:

Prior-authorization requirements for inpatient psychiatric admission or residential substance-use treatment
Concurrent-review protocols that reassess necessity every few days
"Fail-first" or step-therapy rules requiring outpatient therapy before higher levels of care
Medical-necessity criteria drawn from insurer-specific guidelines rather than generally accepted clinical standards
Provider-network admission standards, reimbursement rates, and credentialing timelines

Under federal regulation, plans must be able to demonstrate — in writing, on request — that these NQTLs are applied to mental-health benefits no more stringently than to medical or surgical benefits in the same classification. A plan that requires prior authorization for every partial-hospitalization admission but not for equivalent medical day programs, for instance, must justify the disparity with concrete data.

What the 2024 Final Rule Changed

On September 9, 2024, the Departments of Labor, Health and Human Services, and Treasury jointly issued a final rule tightening enforcement of the parity statute. The rule became effective for plan years beginning on or after January 1, 2025, with certain provisions phased in for 2026. Key changes include:

Requirement	Practical Effect
Written NQTL comparative analysis	Plans must maintain and produce, on request, a documented analysis showing that each NQTL is comparable in design and application to those used for medical/surgical benefits.
Meaningful benefits standard	If a plan covers a condition, it must cover meaningful benefits for that condition in every classification where medical benefits are offered.
Outcomes data collection	Plans must collect and evaluate relevant data — denial rates, network composition, out-of-network utilization — to identify material differences in access.
Fiduciary certification (ERISA plans)	Named fiduciaries of ERISA plans must certify that they have engaged in a prudent process to select and monitor service providers responsible for the comparative analysis.

The full text of the rule and a plain-language fact sheet are available from the Employee Benefits Security Administration.

Why Behavioral-Health Claims Are Denied

Federal and state audits have identified a small number of denial patterns that account for most disputed mental-health claims:

Medical necessity. The plan asserts that a lower level of care would suffice — outpatient rather than intensive outpatient, or partial hospitalization rather than residential treatment.
Failure to obtain prior authorization. Care was provided in an urgent context, but the plan applied a routine prior-authorization requirement retroactively.
Out-of-network status. The patient could not find an in-network provider with timely availability and paid out of pocket, then sought reimbursement.
Duration and frequency limits. The plan approves an initial episode but denies continued treatment after a set number of visits or days.
Experimental or investigational designation. Evidence-based interventions — notably certain treatments for eating disorders, autism-spectrum conditions, and post-traumatic stress — are labeled experimental despite substantial clinical support.

Each of these categories can be a legitimate application of coverage terms — or a parity violation, depending on how the same criteria are applied to medical benefits.

The Internal and External Appeals Process

Federal law guarantees enrollees in most non-grandfathered health plans two levels of review after an adverse benefit determination.

Internal appeal

Filed with the plan itself, typically within 180 days of the denial notice. The plan must issue a written decision within 30 days for pre-service claims, 60 days for post-service claims, and 72 hours for urgent care. The reviewer cannot be the same clinician who issued the original denial, and the plan must provide, free of charge, the specific rules, guidelines, and medical evidence relied upon.

External review

If the internal appeal is unsuccessful, most enrollees are entitled to an independent external review conducted by an Independent Review Organization (IRO) or, for self-funded ERISA plans, through the federal external-review process administered by HHS. The IRO's decision is binding on the plan.

Close-up of a person filling out insurance paperwork and an appeal form with a pen

ERISA vs. Non-ERISA Plans

Whether a plan is governed by ERISA determines which forum hears any lawsuit and what remedies are available.

Self-funded employer plans (where the employer bears the claims risk directly, common among large employers) are governed exclusively by ERISA. Suits are filed in federal court, and recovery is generally limited to the value of the denied benefit plus attorney fees under section 502(g).
Fully insured employer plans and individual policies are subject to state insurance law in addition to federal parity requirements. State remedies may include extra-contractual damages, statutory penalties, and, in a small number of states, punitive damages for bad-faith denial.
Government plans (federal employee health benefits, Medicare Advantage, Medicaid managed care) each have their own administrative appeal pathways and are not directly governed by MHPAEA, though most incorporate parity-equivalent standards through separate authority.

Confirming plan type is the first substantive step in any parity dispute. The information is contained in the Summary Plan Description, which the plan administrator must provide within 30 days of a written request.

State Parity Laws and Regulators

Most states have enacted their own mental-health parity statutes that supplement — and in several cases exceed — federal requirements. California's SB 855, New York's Timothy's Law, Illinois's parity enforcement regulations, and Oregon's House Bill 3046 are among the most detailed. State insurance departments retain jurisdiction over fully insured plans and can investigate parity violations, order remediation, and impose civil penalties.

The National Association of Insurance Commissioners maintains a directory of state-level parity resources and complaint portals. Filing a complaint with the state insurance department is free, does not require an attorney, and often produces faster movement than a formal lawsuit.

When to Retain a Mental-Health Parity Attorney

Legal representation is not necessary for every denial. It becomes valuable when one or more of the following conditions apply:

The disputed amount exceeds several thousand dollars in unreimbursed care.
Care has been ongoing and the plan is issuing repeated concurrent-review denials.
The denial rests on medical-necessity criteria that appear inconsistent with generally accepted clinical guidelines (for example, ASAM criteria for substance-use disorders or the LOCUS system for mental-health level-of-care determinations).
The plan has refused to produce its NQTL comparative analysis on request.
The patient is in a self-funded ERISA plan and must file suit in federal court to recover benefits.

Firms specializing in ERISA and mental-health parity litigation typically evaluate cases on contingency or hybrid arrangements. Related consumer-protection frameworks for medical billing and background on employer-sponsored group health plans provide useful context on how the appeals ecosystem interacts with day-to-day coverage decisions.

A Practical Step-by-Step Checklist

Request the full denial letter and the plan's specific medical-necessity criteria in writing.
Obtain a treatment letter from the treating clinician explaining diagnosis, prior treatment history, and the clinical justification for the recommended level of care.
Request the NQTL comparative analysis from the plan administrator, citing 29 CFR §2590.712 and the 2024 final rule.
File the internal appeal within the deadline, attaching the clinician's letter, relevant clinical guidelines, and — where applicable — the request for the comparative analysis.
Escalate to external review if the internal appeal fails; the IRO decision is binding.
File a parallel complaint with the state insurance department (fully insured plans) or the EBSA regional office (ERISA plans).
Retain counsel if the plan does not comply or if the disputed care is ongoing and financially significant.

Frequently Asked Questions

Does mental-health parity apply to short-term limited-duration insurance?

Short-term plans sold outside the Affordable Care Act marketplaces are not subject to MHPAEA and typically exclude or severely limit mental-health benefits. Coverage limitations are disclosed in the plan documents.

Can my employer's plan exclude a specific diagnosis?

Blanket exclusions for a specific mental-health or substance-use diagnosis are generally not permitted in plans subject to MHPAEA when comparable medical conditions are covered. Exceptions exist for certain long-standing statutory exemptions.

How long does an internal appeal take?

The plan must decide urgent-care appeals within 72 hours, pre-service claims within 30 days, and post-service claims within 60 days from receipt of the appeal.

Is telehealth therapy covered on the same terms as in-person therapy?

Under parity, telehealth mental-health services must be covered on the same terms as telehealth medical services within the same classification, though specific coverage varies by plan.

What if my plan denies residential substance-use treatment?

Residential treatment for substance-use disorders is subject to parity analysis. Plans that apply prior-authorization or medical-necessity criteria more stringently than they do for comparable medical inpatient care may be in violation.

Are family and marriage therapy sessions covered?

Coverage of family or couples therapy varies. Where the therapy is a medically necessary component of the treatment plan for a diagnosed mental-health condition of a covered enrollee, it is generally subject to parity requirements.

Can I sue my plan directly for a parity violation?

Under ERISA, enrollees may bring civil actions to recover benefits, enforce plan rights, and clarify future benefit rights. State-law claims may be available for fully insured plans.

Does Medicaid managed care follow parity rules?

Yes. CMS regulations require Medicaid managed-care organizations and CHIP programs to comply with parity requirements substantially equivalent to MHPAEA.

The Data Behind the 2024 Rule

The 2024 final rule did not emerge in a vacuum. It followed years of federally mandated reports to Congress documenting persistent disparities between medical and behavioral coverage. The Department of Labor's most recent report to Congress on MHPAEA enforcement identified NQTL comparative analyses as the single most common area of noncompliance, with the majority of reviewed plans failing to produce documentation that satisfied statutory requirements on the first request.

Separately, actuarial studies commissioned by the Bowman Family Foundation and published through Milliman have consistently found that patients are substantially more likely to go out of network for behavioral care than for medical care, and that reimbursement rates for behavioral providers lag comparable medical rates by a meaningful margin. Whether these disparities constitute parity violations depends on the specific plan analysis, but they help explain why enforcement priorities have shifted toward outcomes data.

Common documentation gaps identified by regulators

Failure to specify the factors used in designing an NQTL and the sources relied upon
Absence of a written comparison to the analogous medical or surgical NQTL
Reliance on internally developed medical-necessity criteria without a documented process for updating them against evolving clinical evidence
Insufficient monitoring of outcomes data — approval rates, denial reasons, out-of-network utilization — across benefit classifications

Autism Spectrum, Eating Disorders, and Other High-Denial Conditions

Certain diagnoses have historically generated a disproportionate share of parity disputes. Applied Behavior Analysis (ABA) for autism spectrum disorder, residential and partial-hospitalization treatment for eating disorders, and evidence-based interventions for post-traumatic stress disorder have each been the subject of state investigations, class-action settlements, and federal enforcement actions.

Families navigating these disputes generally benefit from three additional steps: obtaining a written treatment plan from the clinical team that explicitly maps the recommended intensity of care to a recognized level-of-care system, requesting the plan's specific criteria for approving comparable medical inpatient care, and documenting every prior-authorization interaction in writing, including the credentials and title of the reviewer.

Building the Record for Appeal

The single largest predictor of a successful appeal is the completeness of the administrative record. Under ERISA, the reviewing court is generally limited to the record that was before the plan administrator at the time of the final denial. Anything not submitted during the internal appeal is, in most jurisdictions, unavailable later.

A well-prepared file typically includes the original denial letter, the plan's summary plan description, the certificate of coverage, all relevant clinical records, any second-opinion evaluations, correspondence with the plan, and — where obtained — the NQTL comparative analysis. It also includes the treating clinician's detailed letter of medical necessity, with references to the diagnostic criteria applied, the treatment guidelines followed, and the specific clinical reasoning supporting the recommended level of care.

Prescription Drug Parity

Parity applies to the prescription-drug classification as well. Formulary tiering, prior-authorization requirements, and step-therapy protocols must be applied to psychiatric medications on comparable terms to those used for medical drugs. Recent enforcement actions have focused on prior-authorization requirements imposed on long-acting injectable antipsychotics and medications for opioid-use disorder, where reviewers have found that comparable specialty medical drugs were subject to less stringent controls.

Disclaimer: This article is provided for general informational purposes only and does not constitute legal, medical, insurance, or financial advice. Federal parity regulations, state insurance laws, and plan-specific terms are complex and continue to evolve. Individual circumstances vary substantially. Readers should consult a licensed attorney, patient advocate, or state insurance regulator before taking action based on the information above. All information is drawn from publicly available government and regulatory sources and is current as of publication.